Incidence of opportunistic infections and its predictors among HIV/AIDS patients on antiretroviral therapy in Gondar University Comprehensive and Specialized Hospital, Ethiopia

References

• Mahy M, Marsh K, Sabin K, et al. HIV estimates through 2018: data for decision-making. AIDS (London, England.), 2019;33(Supplement 3):S203–S211.
   PubMedGoogle Scholar
• Ranganathan K, Umadevi KMR. Common oral opportunistic infections in Human Immunodeficiency Virus infection/Acquired Immunodeficiency Syndrome: Changing epidemiology; diagnostic criteria and methods; management protocols. Periodontol 2000. 2019;80(1):177–188.
   PubMed Web of Science ®Google Scholar
• Garey L, Bakhshaie J, Sharp C, Neighbors C, Zvolensky MJ, Gonzalez A. Anxiety, depression, and HIV symptoms among persons living with HIV/AIDS: the role of hazardous drinking. AIDS care. 2015;27(1):80–5.
   Google Scholar
• World Health Organization. Global Health Sector Strategy on HIV 2016-2021. Towards Ending AIDS. World Health Organization; 2016.
   Google Scholar
• Melkamu MW, Gebeyehu MT, Afenigus AD, et al. Incidence of common opportunistic infections in HIV-infected children on antiretroviral therapy at Debre Markos referral hospital in Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis. 2020;20(1):1–12.
   Web of Science ®Google Scholar
• Haileamlak A, Hagos T, Abebe W, et al. Predictors of hospitalization among children on ART in Ethiopia: a cohort study. Ethiop J Health Sci. 2017;27(Suppl 1):53–62.
   PubMedGoogle Scholar
• Mermin J, Were W, Ekwaru JP, et al. Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet. 2008;371(9614):752–759.
   PubMed Web of Science ®Google Scholar
• Candiani TMS, Pinto J, Cardoso CAA, et al. Impact of highly active antiretroviral therapy (HAART) on opportunistic infections, hospitalizations, and mortality in HIV/AIDS-infected children and adolescents in Belo Horizonte, Minas Gerais State, Brazil. Cad Saúde Pública. 2007;23(suppl 3):S414–S423.
   PubMedGoogle Scholar
• Sisay MM, Ayele TA, Gelaw YA, et al. Incidence and risk factors for failure of first-line antiretroviral therapy in HIV-infected children in Amhara regional state, Ethiopia: a retrospective follow-up study. BMJ Open. 2018;8(4):e019181.
   PubMed Web of Science ®Google Scholar
• Federal Ministry of Health. National Guidelines for HIV and AIDS Treatment and Care in Adolescents and Adults. Abuja, Nigeria: Federal Ministry of Health; 2010.
   Google Scholar
• Prasitsuebsai W, Kariminia A, Puthanakit T, et al. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the TREAT Asia Pediatric HIV observational database. Pediatr Infect Dis J. 2014;33(7):747–752.
   PubMed Web of Science ®Google Scholar
• Miller V, Mocroft A, Reiss P, et al. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann Intern Med. 1999;130(7):570–577.
   PubMed Web of Science ®Google Scholar
• Dore GJ, et al. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquired Immune Defic Syndr. 1999;29(4):388–395.
   Google Scholar
• Benson CA, et al. Treating Opportunistic Infections in HIV-Infected Adults and Adolescents. CDC, National Institutes of Health, and HIV Medicine Association/Infectious Diseases Society of America Recommendations; 2004.
   Google Scholar
• Google. www.sitefinder.tghn.org/sites/university-of-gondar-hospital/.
   Google Scholar
• Taye BW, Yassin MO, Kebede ZT. Quality of emergency medical care in Gondar University Referral Hospital, Northwest Ethiopia: a survey of patient’s perspectives. BMC Emerg Med. 2014;14(1):2–10.
   PubMedGoogle Scholar
• Olenina L, Patel IP, Portal AP. Health Information Symptoms of AIDS.
   Google Scholar
• Assefa Y, Gilks CF, Lynen L, et al. Performance of the Antiretroviral Treatment Program in Ethiopia, 2005-2015: strengths and weaknesses toward ending AIDS. Int J Infect Dis. 2017;60:70–76.
   PubMed Web of Science ®Google Scholar
• Mutasa-Apollo T, Shiraishi RW, Takarinda KC, et al. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe’s National Antiretroviral Therapy Programme, 2007–2010. PLoS One. 2014;9(1):e86305.
   PubMed Web of Science ®Google Scholar
• Degavi G. Influence of lost to follow up from antiretroviral therapy among retroviral infected patients at tuberculosis centers in public hospitals of Benishangul-Gumuz, Ethiopia. HIV AIDS (Auckl). 2021;13:315–327.
   PubMedGoogle Scholar
• World Health Organization. Global database on body mass index. BMI Classification [Internet]. Geneva, Switzerland: WHO; 2004.
   Google Scholar
• World Health Organization. Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach-2010 Revision. World Health Organization; 2010.
   Google Scholar
• Toperesu E. Effects of the Income Generating Activities Project On the livelihood of Volunteer Care Givers and their service delivery to HIV/AIDS-affected households; A case of Sedze cluster in Chitsanza ward, Zimbabwe2010.
   Google Scholar
• Alene KA, Nega A, Taye BW. Tuberculosis incidence and predictors among adult people living with HIV at the University of Gondar Referral Hospital in Northwest Ethiopia. BMC Infect Dis. 2013;13(1):1–9.
   PubMedGoogle Scholar
• G YT, Yaya Y, Jerene D, et al. Incidence of opportunistic infections among adult HIV positive people receiving co-trimoxazole prophylaxis. IJPHS. 2015;4(3):172–179.
   Google Scholar
• Arefaine ZG, Abebe S, Bekele E, et al. Incidence and predictors of HIV-associated opportunistic infections following initiation of highly active antiretroviral therapy at Ayder Referral Hospital in Mekelle, Ethiopia: A retrospective single-center cohort study. PLoS One. 2020;15(4):e0229757.
   PubMed Web of Science ®Google Scholar
• Aemro A, Jember A, Anlay DZ. An inlay, Tuberculosis incidence and predictors among adults on antiretroviral therapy at Debre Markos referral hospital in Northwest Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):1–11.
   Web of Science ®Google Scholar
• Nissapatorn V. AIDS-related opportunistic infections in Hospital Kuala Lumpur. Jpn J Infect Dis. 2003;56(5/6):187–192.
   PubMed Web of Science ®Google Scholar
• Rubaihayo J, Tumwesigye NM, Konde-Lule J, et al. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda. BMC Res Notes. 2016;9(1):1–16.
   PubMedGoogle Scholar
• Luo B, Sun J, Cai R, et al. Spectrum of opportunistic infections and risk factors for in-hospital mortality of admitted AIDS patients in Shanghai. Medicine. 2016;95(21):e3802.
   PubMed Web of Science ®Google Scholar
• Badri M, et al. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS 2001;15(9):1143–1148.
   PubMed Web of Science ®Google Scholar
• Dalbo M, Tamiso A. Incidence and predictors of tuberculosis among HIV/AIDS infected patients: a five-year retrospective follow-up study. AIDS. 2016;6(2):70–81.
   Google Scholar
• Abebe A, et al. Assessing the effect of highly active antiretroviral treatment and associated factors on the incidence of tuberculosis among adult HIV positive individuals in Assela, Ethiopia. J Health Med Inform. 2014;5:2.
   Google Scholar
• Liu E, Makubi A, Drain P, et al. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS. 2015;29(11):1391–1399.
   PubMed Web of Science ®Google Scholar
• Haraka F, Glass TR, Sikalengo G, et al. A bundle of services increased ascertainment of tuberculosis among HIV-infected individuals enrolled in an HIV cohort in rural sub-Saharan Africa. PLoS One. 2015;10(4):e0123275.
   PubMed Web of Science ®Google Scholar
• Azanaw MM, Derseh NM, Yetemegn GS, et al. Incidence and predictors of tuberculosis among HIV patients after initiation of antiretroviral treatment in Ethiopia: a systematic review and meta-analysis. Trop Med Health. 2021;49(1):1–11.
   PubMed Web of Science ®Google Scholar
• Azanaw MM, et al., Incidence and Predictors of tuberculosis among HIV patients after initiation of ART treatment in Ethiopia: a systematic review and Meta-analysis. 2019.
   Google Scholar
• Holmes CB, Wood R, Badri M, et al. CD4 decline and opportunistic infection incidence in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr. 2006;42(4):464–469.
   PubMed Web of Science ®Google Scholar
• Zhang K, Dong P-L, Qiang L-Y. Analysis of the incidence of opportunistic infections related to the change of CD_4∼+ lymphocyte count in people living with HIV/AIDS. J China AIDS/STD. 2003;1.
   Google Scholar
• Dame D, et al. Common opportunistic infections, and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC Research Notes. 2013;6(1):1–7.
   PubMedGoogle Scholar
• Temesgen B, Kibret GD, Alamirew NM, et al. Tuberculosis prevalence and predictors in HIV-positive adults receiving antiretroviral therapy at Debre Markos referral hospital in Northwest Ethiopia: a retrospective record review. BMC Public Health. 2019;19(1):1–9.
   PubMed Web of Science ®Google Scholar
• Hailu T, et al., Prevalence of opportunistic infections and associated factors among HIV-infected patients on antiretroviral therapy in Eastern Zone of Tigray, Ethiopia: a cross-sectional study. 2020.
   Google Scholar
• Kebebew K, Wencheko E. Survival analysis of HIV-infected patients under antiretroviral treatment at the Armed Forces General Teaching Hospital, Addis Ababa, Ethiopia. Ethiop J Health Dev. 2012;26(3):186–192.
   Web of Science ®Google Scholar
• Kebede HK, Mwanri L, Ward P, et al. Predictors of lost follow-up from antiretroviral therapy among adults in sub-Saharan Africa: a systematic review and meta-analysis. Infect Dis Poverty. 2021;10(1):1–18.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Mekonnen D, Kindie M. Incidence and predictors of tuberculosis among adult people living with HIV/AIDS in Afar public health facilities, Northeast Ethiopia. AIDS 2015;1:3–10.
   Google Scholar
• Mu W, Zhao Y, Sun X, et al. Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study. AIDS Care. 2014;26(9):1127–1135.
   PubMed Web of Science ®Google Scholar